Safety and Efficacy of a Glaucoma Drug Delivery System

• Status: Completed
• Trial end date: 2009-04-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the ocular safety and efficacy of a glaucoma drug delivery system in open-angle glaucoma or ocular hypertension.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Vistakon Pharmaceuticals

Criteria

Inclusion Criteria:

• Man or woman 21 years of age or greater

• must have open angle glaucoma or ocular hypertension.

• Corrected visual acuity in each eye of 20/200 or better.

Exclusion Criteria:

• Previous glaucoma intraocular surgery or refractive surgery.

• Planned contact lens use during the study.

• Clinically significant ocular or systemic disease that might interfere with the study.

• Use of chronic corticosteroids by any route.